Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2

Leukemia. 2007 Jan;21(1):178-80. doi: 10.1038/sj.leu.2404460. Epub 2006 Nov 2.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzimidazoles / pharmacology*
  • Benzimidazoles / therapeutic use
  • Casein Kinase II / antagonists & inhibitors*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Fusion Proteins, bcr-abl*
  • Humans
  • Leukemia, Lymphoid / drug therapy*
  • Leukemia, Lymphoid / enzymology
  • Leukemia, Lymphoid / genetics
  • Mice

Substances

  • 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole
  • 4,5,6,7-tetrabromobenzimidazole
  • Benzimidazoles
  • Fusion Proteins, bcr-abl
  • Casein Kinase II